Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Join | Sign in

  News Archive

Drugs that Activate Brain Stem Cells May Reverse Multiple Sclerosis
Tuesday, April 21, 2015
NIH-funded study identifies over-the-counter compounds that may replace damaged cells.

Porvair Filtration Group Receives Queen’s Award for Enterprise in International Trade
Tuesday, April 21, 2015
This award had been made in recognition of Porvair’s substantial growth in overseas business, achieving increased year-on-year growth in sales of exported products over the past three years.

Optibrium and ChemAxon Collaborate
Wednesday, April 15, 2015
Interface between StarDrop and Plexus facilitates seamless access to both software platforms.

Medivir and Cancer Research Technology Collaborate
Tuesday, April 14, 2015
Collaboration will lead to development of new class of cancer drugs.

Allergy Drug Inhibits Hepatitis C in Mice
Friday, April 10, 2015
NIH study suggests alternative drug to treat virus.

Confluence Signs Co-Development and Marketing Agreement with AOP Orphan
Friday, April 03, 2015
Agreement to co-develop and market Confluence’s lead asset in Europe and the Middle East.

ISA Scientific, Yissum, Hadasit and KIR to Collaborate
Friday, April 03, 2015
Licensing and collaboration agreement on treating diabetes and other serious health conditions with cannabidiol.

$2.1 Million Grant Targets Antibiotic Resistance
Thursday, April 02, 2015
Grant to develop small-molecules that counter antibiotic resistance in Gram-negative bacteria.

Basilea In-Licenses Targeted Cancer Therapy
Thursday, April 02, 2015
Basilea Pharmaceutica Ltd. has entered into a license agreement for novel panRAF kinase inhibitors with a consortium of organizations including The Institute of Cancer Research, London, Cancer Research Technology, the Wellcome Trust and The University of Manchester.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 4038
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters